for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

UPDATE 1-King completes animal unit review

* King determines not to change structure of animal unit

* King conducted review to determine potential value

CHICAGO, April 30 (Reuters) - King Pharmaceuticals Inc KG.N said it has completed its review of its Alpharma Animal Health business and has determined that it will not alter its current structure.

In January, King said it was conducting a review of the business unit, looking at its potential value and overall strategic position.

King shares closed at $9.85 on the New York Stock Exchange on Thursday. (Reporting by Debra Sherman, editing by Gerald E. McCormick)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up